Tag: Guerbet
Guerbet: good start to the year
resume Published on 04/25/2024 at 6:02 p.m. Photo credit © ChaunuPictures (Boursier.com) — Guerbet publishes…
Intrasense / Guerbet: obtaining CE certification for Myrian 2.12
(Boursier.com) — Intrasense specialist in medical imaging software solutions and designer of Myrian, and Guerbet announce that the Myrian 2.12 platform has obtained the CE certificate under MDR, integrating the…
Guerbet: CE certificate for a platform
(CercleFinance.com) – Intrasense, specialist in medical imaging software solutions and designer of Myrian®, and Guerbet, world leader in medical imaging, announce that the Myrian® 2.12 platform has obtained the CE…
Guerbet: sharp rise
(Boursier.com) — Guerbet topped the charts this Friday morning thanks to a gain of 6.6% to 32.5 euros. The stock is gaining ground after losing ground following the presentation of…
Guerbet: two new appointments within its management team
(AOF) – Guerbet, specialist in contrast products and solutions for medical imaging, announces the strengthening of its management team with two new appointments. Christine Allard and Eva Ohlsson join the…
Exceptional volumes today: X-Fab, Guerbet
During this stock market session on Friday February 9, 2024, particularly high trading volumes were detected on the French market. Today, it is the X-Fab stock that stands out, with…
Guerbet under the sign of growth
(AOF) – Guerbet announces 2023 turnover of 785.7 million euros, an increase of 4.3% over one year, 6.4% at constant exchange rate (CER) and 5.9% at comparable scope. The global…
Guerbet: death of Michel Guerbet, the son of the founder
(Boursier.com) — The Group Guerbet announces the death of Michel Guerbet, which occurred on January 23 at the age of 92. Historical figure of the group, Michel Guerbet was the…
Guerbet obtains marketing authorization for its Elucirem product in Europe
(AOF) – The marketing authorization (AMM) for Elucirem (Gadopiclenol) was granted to Guerbet by the European Commission on the basis of the positive opinion of the Committee for Medicinal Products…
Guerbet: objectives confirmed, the stock on the rise
By Jean-Baptiste André Published on 10/20/2023 at 2:04 p.m. Photo credit © Guerbet (Boursier.com) — Guerbet increases 1.4%…
Guerbet: turnover up 2.7% over 9 months
(AOF) – Guerbet announces turnover as of September 30, 2023 at 573.9 million euros, up 0.8% compared to the same period in 2022. At constant exchange rate (CER) the growth…
Guerbet: turnover up 2.7% over 9 months – 10/19/2023 at 6:22 p.m.
(AOF) – Guerbet announces turnover as of September 30, 2023 at 573.9 million euros, up 0.8% compared to the same period in 2022. At constant exchange rate (CER) the growth…